Rare diseases
Investigational molecules
Locations
Back to Spain60 clinical trials in Ferrol, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)SpainTesting icotrokinra compared to placebo for adults and adolescents with moderately to severely active ulcerative colitis
SpainA Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
SpainA study comparing erdafitinib delivery system to chemotherapy for patients with high-risk non-muscle-invasive bladder cancer who received BCG treatment
SpainLong-term safety study of subcutaneous vedolizumab in children and adolescents with ulcerative colitis or Crohn's disease
SpainStudy on Sacituzumab Govitecan for Patients with Advanced Differentiated and Anaplastic Thyroid Cancer
SpainStudy on Crohn's Disease: Evaluating Risankizumab's Effects in Children Aged 2 to 17 with Moderate to Severe Symptoms
SpainStudy of Vedolizumab for Children with Moderate to Severe Ulcerative Colitis or Crohn's Disease
SpainEffect of lenbelintide (AZD6234) on body weight in adults with type 2 diabetes and obesity or overweight
SpainEfficacy and Safety of Alogliptin Plus Empagliflozin Compared with Alogliptin Alone or Empagliflozin Alone in Adults with Type 2 Diabetes on Metformin
SpainKAI-9531 in Adults With Obesity or Overweight and Diabetes
SpainA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
SpainThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on innovative treatments for Type 2 Diabetes and obesity management. Studies evaluate new insulin formulations and novel therapeutic approaches for weight management.
Multiple trials exploring dual-action medications targeting both obesity and associated conditions.
Comprehensive research into inflammatory bowel conditions, including Ulcerative Colitis and Crohn's Disease. Studies focus on novel therapeutic agents and treatment approaches.
Innovative therapies being evaluated for both induction and maintenance of remission.
Studies targeting cardiovascular disease prevention and treatment, including research on stroke prevention in atrial fibrillation and atherosclerosis management.
Focus on both preventive measures and therapeutic interventions for various cardiac conditions.
Investigation of treatments for chronic kidney disease, including both diabetic and non-diabetic conditions. Research evaluates novel therapeutic combinations and standalone treatments.
Emphasis on delaying disease progression and improving outcomes in kidney disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
